Olema Pharmaceuticals Inc (OLMA) USD0.0001
0.23%- This stock can be held in a
Stocks and Shares ISASell:$5.13
Buy:$5.14
Change:
$0.30
(6.20%)
$0.30
(6.20%)Market closed | Prices delayed by at least 15 minutes
Sell:$5.13
Buy:$5.14
Change:$0.30
(6.20%)
$0.30
(6.20%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 8 January 2025 | BAIN CAPITAL LIFE SCIENCES INVESTORS LLCPrivate Equity | Buy Regular purchase transaction | 300,000 | $5.76 | $1,727,370.00 | 7,800,000 |
| 11 December 2024 | Cyrus L. HarmonDirector | Sell Tax related | 7,958 | $8.66 | $68,916.28 | 764,319 |
| 11 December 2024 | Cyrus L. HarmonDirector | Sell Tax related | 179 | $9.39 | $1,680.81 | 764,140 |
| 11 December 2024 | David C. MylesChief Level Officer | Sell Tax related | 13,314 | $8.66 | $115,299.24 | 598,633 |
| 11 December 2024 | David C. MylesChief Level Officer | Sell Tax related | 300 | $9.39 | $2,817.00 | 598,333 |
| 11 December 2024 | Shane William Charles KovacsCFO | Sell Tax related | 17,950 | $8.66 | $155,447.00 | 543,955 |
| 11 December 2024 | Shane William Charles KovacsCFO | Sell Tax related | 406 | $9.39 | $3,812.34 | 543,549 |
| 11 December 2024 | Sean P. BohenPresident/CEO | Sell Tax related | 55,907 | $8.66 | $484,154.62 | 242,929 |
| 11 December 2024 | Sean P. BohenPresident/CEO | Sell Tax related | 1,267 | $9.39 | $11,897.13 | 241,662 |
| 11 December 2024 | Naseem ZojwallaOther Level A | Sell Tax related | 14,202 | $8.66 | $122,989.32 | 115,829 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 1 August 2024 | PARADIGM BIOCAPITAL ADVISORS LPInvestment Management Company | Sell Regular sell transaction (market) | 1,870,499 | $14.92 | $27,898,492.59 | 4,720,482 |
| 4 December 2024 | BVF PARTNERS LPPrivate Equity | Buy Regular purchase transaction | 1,258,027 | $9.08 | $11,422,759.36 | 3,055,554 |
| 4 June 2024 | LOGOS OPPORTUNITIES FUND I LPHedge Fund | Sell Regular sell transaction (market) | 700,000 | $14.85 | $10,395,000.00 | 700,761 |
| 4 December 2024 | BVF PARTNERS LPPrivate Equity | Buy Regular purchase transaction | 1,047,044 | $9.08 | $9,507,054.82 | 2,465,780 |
| 1 August 2024 | PARADIGM BIOCAPITAL ADVISORS LPInvestment Management Company | Sell Regular sell transaction (market) | 529,501 | $14.92 | $7,897,507.42 | 783,118 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.